US FDA approves expanded use of Bristol-Myers Squibb’s HCV drug Daklinza

Fred Poordad

Transplant Center

Press/Media: Press / Media

Period	Feb 8 2016

Media coverage

1

Media coverage

Title US FDA approves expanded use of Bristol-Myers Squibb’s HCV drug Daklinza
Media name/outlet PharmaBiz
Country India
Date 2/8/16
Persons Fred Poordad